Last week, Novo Nordisk NVO announced that its popular semaglutide-based GLP-1 injections, Wegovy (for obesity) and Ozempic ...

Novo Nordisk’s stock tumbles after its oral GLP-1 drug didn’t show a statistically significant benefit over a placebo against ...

Amphastar Pharmaceuticals, Inc. is a U.S.-based specialty pharmaceutical company known for developing, manufacturing, and ...

Users of this method experience a reduction in their waist measurements. There's no doubt I could do with losing a few pounds ...

In terms of value, the Pharmaceutical Packaging Market size projected to reach USD 364.11 billion by 2030 from USD 174.85 ...

Phase 1 Study in Non-Small Cell Lung Cancer Combined Reqorsa® Gene Therapy with Tagrisso® AUSTIN, Texas, Nov. 24, 2025 /PRNewswire/ -- Genprex, Inc. ("Genprex" or ...

Also in today’s newsletter, Indonesia’s GoTo paves way for merger with rival, and Trump’s retribution campaign takes a hit ...

First patient randomized into HELIOS-3, which along with HELIOS-2 form the basis of AXPAXLI's registrational program in non-proliferative diabetic retinopathy (NPDR) HELIOS-2 and HELIOS-3 are global ...

A common hot beverage costing a mere 4p could "mimic" the effects of weight loss medication, suggests recent findings.

So far, the Q3 earnings season is off to a positive start. As of Nov. 21, 95% of S&P 500 companies have reported results, ...